Association of interferon gamma gene polymorphism and susceptibility to hepatitis C virus infection in Egyptian patients: A multicenter, family-based study
- PMID: 30483551
- PMCID: PMC6207041
- DOI: 10.1002/jgh3.12024
Association of interferon gamma gene polymorphism and susceptibility to hepatitis C virus infection in Egyptian patients: A multicenter, family-based study
Abstract
Background and aim: Polymorphisms in some genes may influence the persistence of hepatitis C virus (HCV) infection, clinical outcome, HCV replication, and liver damage. This study was conducted to investigate the role of the interferon gamma (IFN-γ) gene at (+874 T/A, -764 G/C, -179 C/A) single-nucleotide polymorphisms (SNPs) and its receptor (IFN-γR2) at (rs 2786067 A/C) SNP in the susceptibility of Egyptian families to HCV infection with high-resolution techniques.
Methods: In total, 517 Egyptian families, with 2246 subjects, were recruited to this study from the Upper and Lower Egypt governorates and were classified into three groups: 1034 patients with chronic hepatitis C virus, 108 subjects with spontaneous virus clearance (SVC), and 1104 subjects as a healthy control group. All subjects were genotyped for (+874 T/A, rs2430561, -764 G/C, rs2069707, -179 C/A, rs2069709, and rs 27860067, A/C) SNPs of the IFN-γ gene using the allelic discrimination real-time polymerase chain reaction technique and were confirmed using sequence-based typing.
Results: The carriage of T allele of (+874) IFN-γ is a risky allele and was significantly higher in chronic hepatitis C more than other two groups (odds ratio [OR]: 2.6646, P < 0.0002). On the other hand, the C allele of (-764, rs2069707) is a protective allele and was higher in SVC than the other two groups (OR: 0.2709, P < 0.0001). However, both (-179 C/A, rs 2069709) and (rs 27860067, A/C) SNPs are not polymorphic enough to be studied in the Egyptian population.
Conclusions: HCV infection is associated with the T allele of (+874 rs2430561), while SVC of HCV is associated with the C allele of (-764, rs2069707) of the IFN-γ gene.
Keywords: gene polymorphism; hepatitis C virus susceptibility; interferon gamma; intrafamilial; viral clearance.
Figures











Similar articles
-
Role of interferon gamma and tumor necrosis factor-related apoptosis-inducing ligand receptor 1 single nucleotide polymorphism in natural clearance and treatment response of HCV infection.Viral Immunol. 2015 May;28(4):222-8. doi: 10.1089/vim.2014.0111. Epub 2015 Mar 23. Viral Immunol. 2015. PMID: 25798684
-
Association of genetic polymorphisms of chemokines and their receptors with clearance or persistence of hepatitis C virus infection.Br J Biomed Sci. 2019 Jan;76(1):11-16. doi: 10.1080/09674845.2018.1518299. Epub 2018 Oct 29. Br J Biomed Sci. 2019. PMID: 30175654
-
Association between interferon-gamma (IFN-γ) gene polymorphisms (+874A/T and +2109A/G), and susceptibility to hepatitis B viral infection (HBV).J Appl Biomed. 2022 Mar;20(1):37-43. doi: 10.32725/jab.2022.001. Epub 2022 Jan 12. J Appl Biomed. 2022. PMID: 35099129
-
Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.Infect Genet Evol. 2013 Oct;19:113-9. doi: 10.1016/j.meegid.2013.06.025. Epub 2013 Jul 5. Infect Genet Evol. 2013. PMID: 23831932 Review.
-
Predictive power of Interleukin-28B gene variants for outcome of Hepatitis C Virus genotype 4 in Egyptians: A systematic review and meta-analysis.Clin Res Hepatol Gastroenterol. 2021 Mar;45(2):101480. doi: 10.1016/j.clinre.2020.06.006. Epub 2020 Jul 1. Clin Res Hepatol Gastroenterol. 2021. PMID: 32622719
Cited by
-
Interrelationship between Toll-like receptors and infection after orthotopic liver transplantation.World J Transplant. 2020 Jun 29;10(6):162-172. doi: 10.5500/wjt.v10.i6.162. World J Transplant. 2020. PMID: 32742949 Free PMC article. Review.
References
-
- Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin. Microbiol. Infect. 2011; 17: 107–15. - PubMed
-
- World Health Organization . Hepatitis C‐Fact Sheet (No 164); 2014; http://www.who.int/mediacentre/factsheets/fs164_apr2014/en/
-
- Khattab MA, Ferenci P, Hadziyannis SJ et al Management of hepatitis C virus genotype 4: recommendations of an international expert panel. J. Hepatol. 2011; 54: 1250–62. - PubMed
-
- Wantuck J, Ahmed A, Nguyen M. Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6. Aliment. Pharmacol. Ther. 2014; 39: 137–47. - PubMed
-
- Metz P, Reuter A, Bender S, Bartenschlager R. Interferon‐stimulated genes and their role in controlling hepatitis C virus. J. Hepatol. 2013; 59: 1331–41. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous